Nicolas Gendron Shares A Great Example of How Climate Considerations Become Part of Medical Decision-Making
Nicolas Gendron, Research Fellow, Hematologist at Boston Children’s Hospital, shared on LinkedIn:
“Very pleased to see our work on the carbon footprint of direct oral anticoagulants featured in Le Quotidien du Médecin.
A great example of how climate considerations are now becoming part of medical decision-making, without compromising quality or safety of care. Let’s keep moving toward low-carbon healthcare.
Thank you Le Quotidien du Médecin for highlighting this work.
Original article in Haematologica Journal.”
Title: Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism
Authors: Laurence Chery, Zahra Hassani, Lise Durand, Dorothee Boisseau, Victorien Monguillon, David Grimaldi, Sebastien Taillemite, Benjamin de Sainte Marie, Nicolas Gendron
Also read.
Title: Dabigatran is 3 to 36 times more polluting than other DOACs, according to a French study.
Authors: Damien Coulomb
Never miss updates from Nicolas Gendron with Hemostasis Today.
-
May 30, 2026, 08:59Li-Chia Chen: Advancing Patient Care Through Pharmacist Innovation at KUTRRH
-
May 30, 2026, 08:58Ben Creagh-Brown: How Should HI-PEITHO Influence the Management of Intermediate-Risk Pulmonary Embolism?
-
May 30, 2026, 08:56Reidiel Suárez Borges: Understanding the INR in Anticoagulation Management
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products
-
May 29, 2026, 17:22Brian Schiro: Excited to Provide Guideline Based Care at the Aortic Center
-
May 29, 2026, 17:20Martin Widschwendter: How Molecular Detection Tests Could Transform Endometrial Cancer Care
-
May 29, 2026, 17:18Nina Lansbury: Supporting a Period Friendly World With Menstrual Health Research and Education
-
May 29, 2026, 17:16Ipsita Chatterjee: Red is Not Shame, Red is Power, Red is a Woman
-
May 29, 2026, 16:49Abdulrahman Nasiri: The Evolving Role of Romiplostim in SAA